期刊文献+

托氟啶脂质体的研究 被引量:8

Studies on N_3-O-toluyl-Flulorouracil(TFu)Liposomes
下载PDF
导出
摘要 目的研究托氟啶脂质体的制备方法并考察其在小鼠体内的生物利用度。方法采用薄膜分散-乳匀法制备托氟啶脂质体,用均匀设计法优化托氟啶脂质体的处方和制备工艺;考察脂质体形态、粒径、粒径分布、Zeta电位、包封率、稳定性及体外释药等特性,对脂质体进行质量评价。将托氟啶脂质体分别进行小鼠灌胃和静脉注射给药,眼底静脉丛取血,HPLC测定血药浓度,用DAS(1.0)软件计算药动学参数。结果所制得的脂质体形态圆整,大小均匀;平均粒径400 nm,多分散性指数0.448,Zeta电位-6.4 mV,平均包封率86.9%;脂质体的体外释药符合双相动力学数学模型。小鼠口服脂质体相对于口服托氟啶(TFu)混悬液的生物利用度为199%,小鼠静脉注射脂质体相对于注射TFu溶液的生物利用度为115%。结论采用薄膜分散-乳匀法制备TFu脂质体,工艺简单,包封率较高,且稳定性良好;托氟啶脂质体经小鼠口服给药提高了药物的生物利用度,注射脂质体与注射TFu乙醇-水溶液生物等效。 OBJECTIVE To prepare N3-O-toluyl-Flulorouracil (TFu)]iposomes, evaluate the physicochemic propen, study the pharmacokinetic ctlaracteristies and bioavailability in mice after oral or intravenous administration. METHODS TFu liposomes were prepared by the film dispersion-homogenization techniques. On the base of the single factor investigation, preparation conditions of TFu liposomes were optimized by the uniform design. The morphology of the liposomes was detected by transmission electron microscope. The Zeta potentials and the polydispersity were evaluated by laser scatter analysis. The entrapment efficiencies were determined by protamine aggregation method and the release characteristics in vitro were investigated. The venous blood was collected from the postorbital venous plexuses of mice after a single oral or intravenous administration of TFu liposomes. The plasma concentrations of TFu were measured using ftPI,C method,and pharmacokinetic parameters were calculated by DAS(1.0) program. RESULTS The liposomes were spherical vesicles with uniform sizes. The mean diameter of TFu liposomes was 400 nm, the polydispersity index was 0. 448, the Zeta potential was -6.4 mV, and the mean entrapment efficiency of TFu liposomes was 86. 96%. The release behavior of TFu from lipnsomes in vitro was fitted to the Bioexponential model. The pharmacokinetic study showed the relative bioavailability of TFu liposomes were 199% arid 115% after oral and intravenous administrated in mice, respectively. CONCLUSION TFu liposomes have a higher entrapment efficieney and better stability using the film dispersion-homogenization technique. The pharmacokinetic studies in mice indicated that TFu liposomes have higher bioavailability than the reference preparations after oral administration in mice. TFu liposomes are bloequivalent after i.v. administration in mice comparing with the reference preparations.
机构地区 山东大学药学院
出处 《中国药学杂志》 CAS CSCD 北大核心 2007年第6期445-449,共5页 Chinese Pharmaceutical Journal
关键词 托氟啶 脂质体 质量评价 生物利用度 N3-O-toluyl-Flulorouracil ( TFu ) liposomes quality evaluation bioavailability
  • 相关文献

参考文献8

  • 1李青,冯奉仪,韩军,隋广杰,朱延光,张阳,张珍华,黎莉,王平辉,周美珍,张应潮.抗癌新药阿托氟啶Ⅲ期临床研究报告[J].癌症,2002,21(12):1350-1353. 被引量:4
  • 2YAN M X.The synthesis and proclinical study of mutiple-grade prodrugs of 5-flulomuracil[D].Shandong University post-graduate dissertation(山东大学硕士研究生学位论文),2004.
  • 3FAHR A,HOOGEVEST P V,MAY S,et al.Transfer of lipophilie drugs between liposomal membranes and biological interfaces:consequences for drug delivery[J].Eur J Pharm Sci,2005,26(3-4):251-265.
  • 4ANDRESEN T L,JENSEN S S,JORGENSEN K Advanced strategies in liposomal cancer therapy:problems and prospects of active and tumor specific drug release[J].Prog Lipid Res,2005,44(1):68-97.
  • 5PING Q N.Modern Pharmaceutics(现代药剂学)[M].Beijing:Chinese Medicine Science and Technology Publishing Press,1998:608.
  • 6AVGOUSTAKIS K,BELETSI A.PANAGI Z.PLGA-mPEG nanopartieles of eisplatin:in vitro nanoparticle degradation,in vitro drug release and in vivo drug residence in blood properties[J].J Controlled Release,2002,79(1-3):123-135.
  • 7YANGYB TANGZQ ZHANGP.The pharmacokineties of atofluding in cancer patients.中国新药杂志,2004,10(3):196-198.
  • 8EL-SAMALIGY M S,AFIFI N N,MAHMOUD E A.Increasing bioavailability of silymarin using a buccal liposomal delivery system:Preparation and experimental design investigation[J].Int J Pharm,2006,308(1-2):140-148.

二级参考文献4

  • 1Waters JS, Ross PJ, Popescu RA, et al. New approaches to the treatment of gastrointestinal cancer [J]. Digestion, 1997,58(4): 508-528.
  • 2Cullinan SA, Moertel CG, Wieand HS, et al. Controlled evaluation of three drug combination regimens versus Fluorouracil alone for therapy of advanced gastric cancer [J]. J Clin Oncol, 1994, 12(3): 412-416.
  • 3李青,杨玉彬,冯奉仪,汤致强.国产抗癌新药阿托氟啶Ⅰ期临床研究[J].癌症,2000,19(12):1131-1133. 被引量:5
  • 4李青,冯奉仪,韩军,隋广杰,朱延光,张阳,张珍华,黎莉,王平辉,周美珍,张应潮.国产抗癌新药阿托氟啶Ⅱ期临床研究[J].癌症,2001,20(12):1387-1390. 被引量:1

共引文献5

同被引文献62

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部